Mangalam Drugs & Organics Limited (MANGALAM.NS)

INR 117.16

(-0.66%)

Market Cap (In INR)

1.85 Billion

Revenue (In INR)

3.67 Billion

Net Income (In INR)

-90.71 Million

Avg. Volume

119.71 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
90.8-144.99
PE
-
EPS
-
Beta Value
0.748
ISIN
INE584F01014
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Govardhan Murlidhar Dhoot
Employee Count
-
Website
https://www.mangalamdrugs.com
Ipo Date
2005-05-23
Details
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.